Analyst Ratings for ShockWave Medical
Portfolio Pulse from Benzinga Insights
ShockWave Medical (NASDAQ:SWAV) has received various analyst ratings in the last quarter, with a total of 3 bullish, 2 somewhat bullish, 3 indifferent, and 1 somewhat bearish. The average price target for the stock is $290.44, indicating an upside from the current price of $277.549. This average price target has increased by 8.9% over the past month.
July 10, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ShockWave Medical has received mixed analyst ratings, with an average price target indicating an upside.
The mixed analyst ratings indicate uncertainty, but the average price target, which is higher than the current price and has increased over the past month, suggests potential upside for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100